- Home
- RDWR vs KURA Comparison
RDWR vs KURA Comparison
Compare RDWR & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDWR
- KURA
- Stock Information
- Founded
- RDWR 1996
- KURA 2014
- Country
- RDWR Israel
- KURA United States
- Employees
- RDWR N/A
- KURA N/A
- Industry
- RDWR EDP Services
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RDWR Technology
- KURA Health Care
- Exchange
- RDWR Nasdaq
- KURA Nasdaq
- Market Cap
- RDWR 1.0B
- KURA 1.0B
- IPO Year
- RDWR 1999
- KURA N/A
- Fundamental
- Price
- RDWR $22.95
- KURA $12.08
- Analyst Decision
- RDWR Hold
- KURA Buy
- Analyst Count
- RDWR 3
- KURA 11
- Target Price
- RDWR $32.50
- KURA $25.00
- AVG Volume (30 Days)
- RDWR 219.6K
- KURA 2.2M
- Earning Date
- RDWR 10-29-2025
- KURA 11-04-2025
- Dividend Yield
- RDWR N/A
- KURA N/A
- EPS Growth
- RDWR N/A
- KURA N/A
- EPS
- RDWR 0.38
- KURA N/A
- Revenue
- RDWR $294,636,000.00
- KURA $104,029,000.00
- Revenue This Year
- RDWR $11.39
- KURA $68.63
- Revenue Next Year
- RDWR $7.43
- KURA $141.59
- P/E Ratio
- RDWR $59.78
- KURA N/A
- Revenue Growth
- RDWR 10.40
- KURA N/A
- 52 Week Low
- RDWR $18.46
- KURA $5.41
- 52 Week High
- RDWR $31.57
- KURA $12.49
- Technical
- Relative Strength Index (RSI)
- RDWR 43.08
- KURA 66.94
- Support Level
- RDWR $21.75
- KURA $10.86
- Resistance Level
- RDWR $22.85
- KURA $11.88
- Average True Range (ATR)
- RDWR 0.74
- KURA 0.88
- MACD
- RDWR 0.06
- KURA 0.08
- Stochastic Oscillator
- RDWR 60.63
- KURA 85.86
About RDWR Radware Ltd.
Radware Ltd provides cyber security and application delivery solutions. The company provides solutions for cloud, on-premises, and software-defined data centers (SDDC). The solutions of the company secure the digital experience by providing infrastructure, application, and network protection and availability services to enterprises globally. The business segments of the company are Radware's Core Business and The Hawks' Business. The company derives maximum revenue from Radware's Core Business. It generates the majority of its revenue from the United States.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.